← back to search

Behnam Nabet

Fred Hutch Cancer Center ·
🔎 Find collaborators in Molecular Biology · Immunology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, interferon and immune responses, and RNA Interference and Gene Delivery.
h-index
34
citations
8,383
works
132
NIH funding
primary concept
Biology
email

Recent publications

Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models
Journal of Clinical Investigation 2024cited by 14position: middledoi
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells
Cell chemical biology 2022cited by 43position: middledoi
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Cancer Cell 2021cited by 113position: middledoi
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
Nature Communications 2020cited by 308position: firstdoi
Discovery of a selective inhibitor of doublecortin like kinase 1
Nature Chemical Biology 2020cited by 113position: middledoi
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Cell chemical biology 2019cited by 274position: middledoi
A Mutation in Histone H2B Represents a New Class of Oncogenic Driver
Cancer Discovery 2019cited by 104position: middledoi
The dTAG system for immediate and target-specific protein degradation
Nature Chemical Biology 2018cited by 1,147position: firstdoi
Mutant NPM1 Maintains the Leukemic State through HOX Expression
Cancer Cell 2018cited by 312position: middledoi
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
Nature Genetics 2018cited by 242position: middledoi
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
eLife 2018cited by 165position: middledoi
YY1 Is a Structural Regulator of Enhancer-Promoter Loops
Cell 2017cited by 1,070position: middledoi
Transcription control by the ENL YEATS domain in acute leukaemia
Nature 2017cited by 325position: middledoi
MELK is not necessary for the proliferation of basal-like breast cancer cells
eLife 2017cited by 194position: middledoi
A compendium of RNA-binding motifs for decoding gene regulation
Nature 2013cited by 1,627position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nathanael S. Gray · Stanford University8 papers (2017–2022)Dennis L. Buckley · Novartis (China)6 papers (2017–2020)James E. Bradner · Novartis (China)6 papers (2017–2020)Georg E. Winter · Austrian Academy of Sciences4 papers (2017–2018)Charles Y. Lin · South Texas Accelerated Research Therapeutics3 papers (2018–2018)Michael A. Erb · Scripps Research Institute3 papers (2017–2018)Justin M. Roberts · Whitehead Institute for Biomedical Research3 papers (2017–2018)Alan L. Leggett · Dana-Farber Cancer Institute3 papers (2018–2020)Shiva Dastjerdi · Boston University3 papers (2017–2018)Thomas G. Scott · University of Virginia3 papers (2017–2018)Eric S. Fischer · Harvard University3 papers (2019–2022)Katherine A. Donovan · Harvard University3 papers (2019–2022)Joshiawa Paulk · Novartis (United States)3 papers (2017–2018)Matthew A. Lawlor · Rutgers, The State University of New Jersey2 papers (2018–2018)Bo Kyung A. Seong · AstraZeneca (Brazil)2 papers (2020–2021)Sirano Dhe‐Paganon · Neuroendocrine Tumor Research Foundation2 papers (2017–2017)Chunshan Quan · Ministry of Education2 papers (2018–2019)Amanda L. Robichaud · AstraZeneca (United States)2 papers (2020–2021)Hyuk‐Soo Seo · Harvard University2 papers (2017–2017)Jun Qi · Harvard University2 papers (2018–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Immunology →